David Stegner: How Fundamental Platelet Research Can Translate Into Therapeutic Innovation
David Stegner, Professor of Vascular Imaging at the Julius Maximilians University of Würzburg, reposted from Boehringer Ingelheim on LinkedIn:
”A strong example of how fundamental platelet research can translate into therapeutic innovation.
Work from University Hospital of Würzburg has identified GPVI as a key driver of thrombo-inflammation in acute ischemic stroke, directly linking platelet biology to clinical outcome.
The collaboration between Boehringer Ingelheim and Emfret Analytics now advances this concept toward clinical application.
Targeting GPVI offers a compelling strategy: inhibiting pathological platelet activation while preserving hemostasis – a critical requirement in stroke therapy.
For the field, this marks an important translational milestone.
For patients, it highlights the potential to improve outcomes beyond current standard-of-care.”
Quoting Boehringer Ingelheim‘s post:
”NEWS: We are collaborating with Emfret Analytics to advance a potential first‑in‑class antibody‑based approach for acute ischemic stroke.
For decades, we have helped transform stroke care.
By targeting the platelet receptor GPVI, this new approach aims to inhibit thrombus formation and growth while maintaining normal hemostasis – designed to complement standard‑of‑care therapies and further improve patient outcomes.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS